Evidence map›Paper›PMID 33800807›Full record

ArticleMicroorganisms2021

Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection.

Ioannis V Kostopoulos, Nikolaos Orologas-Stavrou, Pantelis Rousakis, Chrysanthi Panteli, Ioannis Ntanasis-Stathopoulos, Ioanna Charitaki, Eleni Korompoki, Maria Gavriatopoulou, Efstathios Kastritis, Ioannis P Trougakos and 3 more

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. T Regulatory Cell Subsets Do Not Restore for One Year After Acute COVID-19.International journal of molecular sciences · 2024
    Article
  7. Persistent CD19Frontiers in cellular and infection microbiology · 2024
    Article
  8. SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers.International journal of hematology-oncology and stem cell research · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. A scoping review of the pathophysiology of COVID-19.International journal of immunopathology and pharmacology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Ioannis V KostopoulosDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0003-1152-6959
Nikolaos Orologas-StavrouDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Pantelis RousakisDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Chrysanthi PanteliDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.
Ioannis Ntanasis-StathopoulosDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Ioanna CharitakiDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Eleni KorompokiDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Maria GavriatopoulouDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.
Efstathios KastritisDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0001-8191-5832
Ioannis P TrougakosDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0002-6179-2772
Meletios-Athanasios DimopoulosDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0001-8990-3254
Ourania E TsitsilonisDepartment of Biology, School of Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.ORCID 0000-0001-6954-0740
Evangelos TerposDepartment of Clinical Therapeutics, Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, 11528 Athens, Greece.ORCID 0000-0001-5133-1422
National and Kapodistrian University of Athens · GR

Funding

SYN-ENOSIS 17315/S.A.R.G.-N.K.U.A
6 · The paper itself

Abstract

Persisting alterations and unique immune signatures have been previously detected in the peripheral blood of convalescent plasma (CP) donors at approximately two months after initial SARS-CoV-2 infection. This article presents the results on the sequential analysis of 47 CP donors at a median time of eight months (range 7.5-8.5 months) post infection, as assessed by flow cytometry. Interestingly, our results show a significant variation of the relevant immune subset composition among CP donors. Regarding innate immunity, both non-classical monocytes, and CD11b- granulocytes had fully recovered at eight months post COVID-19 infection. Intermediate monocytes and natural killer (NK) cells had already been restored at the two-month evaluation and remained stable. Regarding adaptive immunity, the COVID-19-related skewed Th1 and Th2 cell polarization remained at the same levels as in two months. However, low levels of total B cells were detected even after eight months from infection. A persisting reduction of CD8+ Tregs and changes in the NKT cell compartment were also remarkable. CP donors present with a unique immune landscape at eight months post COVID-19 infection, which is characterized by the notable restoration of the components of innate immunity along with a persisting imprint of SARS-CoV-2 in cells of the adaptive immunity.

Indexed as

8 monthsconvalescence plasma donorsCOVID-19immune profilingimmune restorationSARS-CoV-2

Identifiers

PMID33800807
PMCPMC8000115
OpenAlexW3135447911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.